Pyxis Oncology, Inc. Common Stock · XNAS · 131 sessions on record
$2.33▼ −0.57 · −19.7%from $2.90 the session before · Sep 30, 2026 close · end of day
Open
$2.38
High
$2.41
Low
$2.12
Day's range
$0.2910% of the previous close
VWAP
$2.27close +2.8% from it
Volume, shares
8.15M8.78× the 20-session average
Traded, $
$18.5M
Trades
26.6K310 shares per trade
Previous close
$2.90−0.57 to the close
Market cap
$194.3Mat the close of Sep 30
Day range72% of the way up
$2.12$2.41
52-week range37% of the way up
$1.26 Mar 30$4.15 Sep 8
−44% from the high · +85% from the low
Options
No listed options on PYXS
Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
consolidated · latest filed Aug 13, 2026 · SEC filings
Profit −$25.3M in the Jun 2026 quarter, consolidated.
Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of PYXS on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue $
Revenue YoY
Profit $
Profit YoY
EPS $
Market on the day
Jun 2026filed Aug 13
—
—
−$25.3M
—
-0.40
0.0%S&P 500 −0.2% · +0.2 pp
Mar 2026filed Aug 13
—
—
−$23.3M
—
-0.37
0.0%S&P 500 −0.2% · +0.2 pp
Dec 2025filed Mar 23
—
—
−$18.1M
—
-0.28
—not reached
Sep 2025filed Nov 3
—
—
−$22.0M
—
-0.35
—not reached
Jun 2025filed Aug 13
$2.8M
—
−$18.4M
—
-0.30
0.0%S&P 500 −0.2% · +0.2 pp
Mar 2025filed Aug 13
—
—
−$21.2M
—
-0.35
0.0%S&P 500 −0.2% · +0.2 pp
Dec 2024filed Mar 18
—
—
−$35.6M
—
-0.62
—not reached
Sep 2024filed Nov 3
—
—
−$21.2M
—
-0.35
—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of PYXS on the consolidated basis, summed from the quarters filed
Year
Revenue $
Revenue YoY
Profit $
Profit YoY
EPS $
FY25to Dec 2025
$13.9M
▼ −14%
−$79.6M
—
-1.28
FY24to Dec 2024
$16.1M
—
−$77.3M
—
-1.32
FY23to Dec 2023
—
—
−$73.8M
—
-1.85
FY22to Dec 2022
—
—
−$120.7M
—
-3.65
FY21to Dec 2021
—
—
−$76.0M
—
-8.95
Fundamentals
consolidated · filings to Jun 2026 · close $2.33 on Sep 30
17 times book value, market cap $194.3M.
Valuation
Market cap
$194.3Mon Sep 30
Price to earnings
—
Trailing EPS
$-1.40diluted · consolidated · four quarters to Jun 2026
Price to book
17consolidated · balance sheet to Jun 2026
Book value a share
$0.14consolidated · balance sheet to Jun 2026
Debt to equity
—
Return on equity
-180%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
—
Shares outstanding
83.4Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—
Revenue growth, 12 months
—
Revenue 3-year CAGR
—trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
−$88.7Mfour quarters to Jun 2026
Profit growth, 12 months
—
Profit 3-year CAGR
—
Shareholding
SEC Forms 3, 4 and 5
No open-market insider buying or selling in the last 90 days.
Insider tradesSEC Forms 3, 4 and 5 · the latest 4
PYXS insider trades
Insider
Trade
Shares
Price
Held after
HUMPHREY RACHELDirector
sold · Apr 14, 2025
1,400
$0.97
95,405
HUMPHREY RACHELDirector
sold · Apr 21, 2025
13,896
$1.03
81,309
HUMPHREY RACHELDirector
sold · Apr 17, 2025
200
$0.97
95,205
Wadhane JitendraOfficer
granted · Mar 24, 2026
109,461
$0.00
512,882
Corporate actions
exchange records
No corporate action on record for PYXS yet.
Price history
131 sessions on record · to Sep 30 · end of day
PYXS is −32.3% over 20 sessions against the S&P 500's +0.1%, 44% below its 52-week high, realised volatility 120% annualised.
Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
Window
From $
PYXS %
S&P 500 %
Difference pp
120 sessionssince Apr 9
$1.61
▲ +45%
▲ +12%
+33
60 sessionssince Jul 7
$3.07
▼ −24%
▲ +2.0%
−26
20 sessionssince Sep 1
$3.44
▼ −32%
▲ +0.11%
−32
5 sessionssince Sep 23
$3.22
▼ −28%
▼ −0.67%
−27
1 sessionsince Sep 29
$2.90
▼ −20%
▼ −0.21%
−19
Averages of the closeclose against each average
5-session average
$2.78close −16% from it
20-session average
$3.27close −29% from it
50-session average
$3.17close −26% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$0.2410% of the close
Average day's range, 20
$0.198.1% of the close
Volume against 20 sessions
8.78×8.15M vs 1.31M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
120%≈ ±7.3% a session · moved more than that on 5 of 20
Realised volatility, 60
130%≈ ±8.1% a session · moved more than that on 16 of 60
Beta to S&P 500, 60
1.18moved with S&P 500 on 28 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
7 up · 11 downof 18
Last 60 sessions
25 up · 31 downof 56
Best session, 250
▲ +26%May 6
Worst session, 250
▼ −26%Aug 11
Short-sale volume
25 sessions · to Sep 30, 2026
Short sales were 57% of reported volume on Sep 30, 2026, against 56% over the last 25 sessions.
Last 10 sessionsshare of the day's reported volume
OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.